CITIID has been repurposed to throw all of its weight behind the fight against COVID-19. It brings to bear upon this global problem over 150 scientists and physicians, the UK’s largest academic containment Level 3 facility, and a range of collaborators from across the UK and beyond. Most importantly, it is integrated with the NHS both locally, through Addenbrooke’s and Royal Papworth Hospitals, and nationally, in particular via the NIHR National BioResource.
Help us tackle COVID-19 through research collaborations, by donating equipment or funding research
The University of Cambridge is co-ordinating activities to address COVID-19, including establishing research collaborations with other research institutions, industrial and charity partners across key disciplines and activities…
Cambridge to spearhead £20million alliance to map spread of COVID-19 coronavirus
The University of Cambridge is to take a leading role in a major national effort to help understand and control the new coronavirus infection (COVID-19) announced today by the Government and the UK’s Chief Scientific Adviser.
Research Excellence and Integrity
The aim of the School is to conduct internationally excellent peer reviewed basic, clinical and translational research relating to a diverse range of medical conditions and treatments.
To maintain the high standards of research practice at Cambridge, the University will uphold the commitments outlined in Universities UK’s Concordat to Support Research Integrity.
The Concordat sets out a series of responsibilities for researchers and employers of researchers, compliance with which is now a condition of HEFCE and RCUK funding
Below are some of the guidelines from the central University and these should be read in addition to the Clinical School policies which can be found on the Research Governance website and the Information Governance website.
- Research Integrity Statement
- Good Research Practice Guidelines
- Misconduct in Research
- Policy on the Ethics of Research Involving Human Participants and Personal Data
- Policy on the Use of Animals in Research (where appropriate)
Further information can be found on the Research Integrity page.
The Clinical School offers students a first class scientific approach to medicine combined with educational programmes that emphasise the development of excellence in the clinical, communication, attitudinal and practical skills required for good medical practice.
Graduate Studies (Higher Degrees)
The Departments and Institutes of the School of Clinical Medicine offer a wide range of research and taught courses, including: research only, research with taught elements, higher doctorates and higher degrees by special regulations.
A study by Stefania Nannoni (Clinical Neurosciences) aimed to clarify the relationship between COVID-19 and acute cerebrovascular diseases (CVD), through a systematic review and…
A study, co-led by Rebecca Fitzgerald (MRC Cancer Unit and CRUK Cambridge Centre Early Detection Programme), has developed a statistical…
A study, led by Julian Rayner and Michael Weekes (both Cambridge Institute for Medical Research), in collaboration with scientists at…
The DIRECT study is a molecular profiling study for patients with diffuse large B cell lymphoma (DLBCL) and closely related…
NOW – a Crowdfunding campaign to connect scientific research to the world of patients by supporting four cancer patients’ associations.…
Cancer cells are surrounded by a diverse range of “normal cells” known as the stroma. The stroma includes immune cells,…